Physician profile
Laura D Mueller
NPI 1194017228
$3,668.27
in general payments reported to CMS, 2019-2025
31 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $358 · 2021: $797 · 2022: $618 · 2023: $779 · 2024: $504 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $651.59 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $577.34 | 2021-2023 | |
| Evofem Biosciences, INC. | $328.06 | 2020-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $300.36 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $219.40 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $199.54 | 2019-2025 | |
| Astellas Pharma US INC | $172.98 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $147.75 | 2023-2024 | Myfembree |
| Pfizer INC. | $133.04 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $132.00 | 2019-2021 | |
| Gilead Sciences, INC. | $121.81 | 2025 | Trodelvy |
| Amgen INC. | $86.35 | 2021-2023 | Prolia, Evenity |
| Avion Pharmaceuticals | $84.68 | 2020-2023 | Balcoltra |
| Daiichi Sankyo INC. | $68.84 | 2019-2022 | |
| Ethicon US, LLC | $53.77 | 2021-2024 | Dermabond Prineo, Stratafix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $52.45 | 2019-2022 | |
| Lupin INC. | $40.23 | 2019-2021 | |
| Molnlycke Health Care US, LLC | $36.77 | 2020 | |
| Duchesnay USA Incorporated | $31.97 | 2019 | |
| Hologic Sales and Service, LLC | $26.51 | 2019-2022 | |
| Minerva Surgical, INC | $26.22 | 2023 | |
| Coopersurgical, INC. | $26.00 | 2022 | |
| Ascend Therapeutics US, LLC | $25.24 | 2021-2023 | |
| Agile Therapeutics, INC. | $17.98 | 2024 | Twirla |
| Novo Nordisk INC | $17.88 | 2021 | |
| Medtronic, INC. | $17.13 | 2023 | Truclear |
| Exact Sciences Corporation | $17.03 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $15.90 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.32 | 2021 | |
| Meditrina | $13.91 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.